This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Save the date!
November 6–8, 2023Munich, Germany

Tomas Landh
Innovation Sourcing VP, Senior Principal Scientist R&D Global S&E, Global R&D BD at Novo Nordisk


Tomas Landh is since 2014 R&D Innovation Sourcing VP and Senior Principal Scientist. He was previously Director Strategy and Innovation Sourcing at Novo Nordisk, Diabetes Research. Tomas joined Novo Nordisk in 2003.

Tomas is currently taking the lead on evaluation of external innovation regarding all aspects of diabetes, rare blood diseases and endocrine disorders. In addition, he works closely with the teams responsible for assessing innovation in the other therapy areas of Novo Nordisk, obesity, CVD, CKD, and NASH. Besides innovative therapies, Tomas is involved in the evaluation of a broad range of technologies, including GT/GE, new drug delivery systems and protein engineering means.

Tomas has more than 30 years of experience of all stages of drug development, from academia, small businesses, foundations and big pharma/biotech. He received his PhD in Biophysical Engineering from Lund’s Institute of Technology.

Agenda Sessions

  • In conversation with Tomas Landh, Novo Nordisk